Medarex
Princeton
About Medarex
Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb® technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 10,001+
- Ticker: nasdaq:MEDX
- Website: medarex.com
- Phone: +1 212-546-4000
Social Profiles
Canonical: https://fsome.com/organization/medarex-3510820 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.